We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

GE HealthCare Technologies Inc (GEHC) USD0.01

Sell:$78.89 Buy:$78.91 Change: $1.32 (1.70%)
NASDAQ:1.03%
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$78.89
Buy:$78.91
Change: $1.32 (1.70%)
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Sell:$78.89
Buy:$78.91
Change: $1.32 (1.70%)
Market closed |  Prices as at close on 20 December 2024 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. The Company provides integrated solutions, services, and data analytics. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. The segment also includes the clinical artificial intelligence (AI) software business. Its PCS segment portfolio consists of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment consists of two business lines: contrast media and molecular imaging.

Contact details

Address:
500 West Monroe Street
CHICAGO
60661
United States
Telephone:
+1 (203) 3604369
Website:
https://www.gehealthcare.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
GEHC
ISIN:
US36266G1076
Market cap:
$35.22 billion
Shares in issue:
456.87 million
Sector:
Health Care Equipment
Exchange:
NASDAQ
Country:
United States
Currency:
US dollar
Indices:
NASDAQ Comb. Composite

Key personnel

  • Peter Arduini
    President, Chief Executive Officer, Director
  • James Saccaro
    Chief Financial Officer, Vice President
  • Kevin O'Neill
    Chief Executive Officer - Pharmaceutical Diagnostics
  • Roland Rott
    Chief Executive Officer - Ultrasound
  • Thomas Westrick
    Chief Executive Officer - Patient Care Solutions
  • Taha Kasshout
    Chief Science and Technology Officer
  • Frank Jimenez
    General Counsel, Corporate Secretary
  • Kenneth Stacherski
    Chief Global Supply Chain and Service Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Options

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.